Marina E Emborg Selected Research

leustroducsin A

1/2013

Neuroprotective Properties of a Novel Non-Thiazoledinedione Partial PPAR- γ Agonist against MPTP.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marina E Emborg Research Topics

Disease

24	Parkinson Disease (Parkinson's Disease) 01/2022 - 12/2002
7	Inflammation (Inflammations) 01/2021 - 08/2011
5	Autonomic Nervous System Diseases (Dysautonomia) 01/2020 - 01/2012
3	Neuroinflammatory Diseases 08/2020 - 01/2013
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2013 - 10/2004
2	Parkinsonian Disorders (Parkinsonism) 08/2011 - 09/2003
2	Stroke (Strokes) 07/2006 - 01/2003
2	Dyskinesias (Dyskinesia) 09/2005 - 01/2002
1	Proteostasis Deficiencies 01/2022
1	Colitis 01/2019
1	Constipation 11/2016
1	Hypersensitivity (Allergy) 01/2012
1	Metaplasia 01/2012
1	Neoplasms (Cancer) 01/2012
1	Nervous System Diseases (Neurological Disorders) 01/2009
1	Disease Progression 01/2007
1	Gliosis 09/2005
1	Tremor (Tremors) 05/2003
1	Infarction (Infarctions) 01/2003
1	Dystonia (Limb Dystonia) 01/2002
1	Huntington Disease (Huntington's Disease) 01/2002

Drug/Important Bio-Agent (IBA)

6	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 08/2020 - 05/2003
5	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 09/2003
5	Oxidopamine (6 Hydroxydopamine)IBA 01/2020 - 01/2012
5	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2013
4	SynucleinsIBA 01/2022 - 11/2015
3	PPAR gammaIBA 01/2020 - 08/2011
3	Pioglitazone (Actos)FDA Link 01/2020 - 08/2011
3	HLA-DR Antigens (HLA-DR)IBA 01/2020 - 11/2016
3	CatecholaminesIBA 01/2020 - 01/2012
2	NeurotoxinsIBA 01/2020 - 01/2014
2	Leucine (L-Leucine)FDA Link 01/2020 - 01/2018
2	Phosphotransferases (Kinase)IBA 01/2020 - 01/2018
2	Serine (L-Serine)FDA Link 01/2019 - 01/2018
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2013 - 08/2011
2	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2012 - 01/2008
1	8-Hydroxy-2'-DeoxyguanosineIBA 01/2019
1	Glial Fibrillary Acidic ProteinIBA 01/2019
1	alpha-SynucleinIBA 01/2019
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2019
1	3-hydroxyephedrineIBA 01/2018
1	Diacetyl (Biacetyl)IBA 01/2018
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2018
1	3-nitrotyrosineIBA 11/2016
1	leustroducsin AIBA 01/2013
1	LSN862IBA 01/2013
1	Nerve Growth Factors (Neurotrophins)IBA 01/2012
1	Neuroprotective AgentsIBA 01/2012
1	Biomarkers (Surrogate Marker)IBA 01/2007
1	Levodopa (L Dopa)FDA LinkGeneric 09/2005
1	U 95666EIBA 09/2005
1	ropinirole (Requip)FDA LinkGeneric 09/2005
1	CreatineIBA 01/2003
1	N-acetylaspartate (N-acetyl aspartate)IBA 01/2003
1	Protons (Proton)IBA 01/2003
1	ImmunophilinsIBA 12/2002
1	LigandsIBA 12/2002
1	3-nitropropionic acidIBA 01/2002
1	Quinolinic AcidIBA 01/2002
1	Apomorphine FDA Link 01/2002

Therapy/Procedure

9	Therapeutics 01/2018 - 09/2005
3	Oral Administration 01/2020 - 08/2011
1	Denervation 01/2012
1	Cell Transplantation 07/2006
1	Injections 01/2002